Pulsed Direct And Constant Direct Currents In The Pilocarpine Iontophoresis Sweat Chloride Test

Background: The classic sweat test (CST) is the golden standard for cystic fibrosis (CF) diagnosis. Then, our aim was compare the production and volume of sweat, and side effects caused by pulsed direct current (PDC) and constant direct current (CDC). To determine the optimal stimulation time (ST) for the sweat collection. To verify the PDC as CF diagnosis option. Methods: Prospective study with cross-sectional experimental intervention. Experiment 1 (right arm): PDC and CDC. ST at 10 min and sweat collected at 30 min. Currents of 0.5; 0.75; 1.0 and 1.5 mA and frequencies of 0, 200, 1,000 and 5,000 Hz applied. Experiment 2 (left arm): current of 1.0 mA, ST at 5 and 10 min and sweat collected at 15 and 30 min with frequencies of 0; 200; 1,000 and 5,000 Hz applied Experiments 1 and 2 were performed with current density (CD) from 0.07 to 0.21 mA/cm2. Experiment 3: PDC was used in typical CF patients with two CFTR mutations screened and or with CF diagnosis by rectal biopsy and patients with atypical CF. Results: 48 subjects (79.16% female) with average of 29.54 ± 8.87 years old were enrolled. There was no statistical difference between the interaction of frequency and current in the sweat weight (p = 0.7488). Individually, positive association was achieved between weight sweat and stimulation frequency (p = 0.0088); and current (p = 0.0025). The sweat production was higher for 10 min of stimulation (p = 0.0023). The sweat collection was better for 30 min (p = 0.0019). The skin impedance was not influenced by ST and sweat collection (p > 0.05). The current frequency was inversely associated with the skin impedance (p < 0.0001). The skin temperature measured before stimulation was higher than after (p < 0.0001). In Experiment 3 (29 subjects) the PDC showed better kappa index compared to CDC (0.9218 versus 0.5205, respectively). Conclusions: The performance of the CST with CDC and PDC with CD of 0.14 to 0.21 mA/cm2 showed efficacy in steps of stimulation and collection of sweat, without side effects. The optimal stimulation time and sweat collection were, respectively, 10 and 30 min.141Di Sant'S Agnese, P.A., Darling, R.C., Perara, G.A., Shea, E., Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas (1953) Am J Dis Child, 86, pp. 618-619Gibson, L.E., Cooke, R.E., A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis (1959) Pediatrics, 23, pp. 545-549Taylor, C.J., Hardcastle, J., Southern, K.W., Physiological measurements confirming the diagnosis of cystic fibrosis. The sweat test and measurements of transepithelial potential difference (2009) Paedia Resp Rev, 10, pp. 220-226Rosenstein, B.J., What is a cystic fibrosis diagnosis? (1998) Clin Chest Med, 19, pp. 423-441Rowe, S.M., Miller, S., Sorscher, E.J., Cystic fibrosis (2005) N Engl J Med, 352, pp. 1992-2001Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation Consensus Report (2008) J Pediatr, 153, pp. S4-e14Castellani, C., Southern, K.W., Brownlee, K., DankertRoelse, J., Duff, A., Farrell, M., Mehta, A., Elborn, S., European best practice guidelines for cystic fibrosis neonatal screening (2009) J Cystic Fibrosis, 8, pp. 153-173Quinton, P.M., Cystic fibrosis: lesson from the sweat gland (2007) Physiology (Bethesda), 22, pp. 212-225Quinton, P.M., Chloride impermeability in cystic fibrosis (1983) Nature, 301, pp. 421-422Collie, J.T.B., Massie, R.J., Jones, O.A.H., LeGrys, V.A., Greaves, R.F., Sixty-Five Years Since the New York Heat Wave: Advances in Sweat Testing for Cystic Fibrosis (2014) Pediatr Pulmonol, 49, pp. 106-117Legrys, V.A., Sweat testing for the diagnosis of cystic fibrosis. Practical considerations (1996) J Pedia, 129, pp. 892-897Gonçalves, A.C., Marson, F.A.L., Mendonça, R.M.H., Ribeiro, J.D., Ribeiro, A.F., Paschoal, I.A., Levy, C.E., Saliva as a potential tool for cystic fibrosisdiagnosis (2013) Diagn Pathol, 8, p. 46Webster, H.L., A clinical appraisal of cystic fibrosis sweat-testing guidelines (2001) Am Clin Lab, 20, pp. 39-42Hammond, K.B., Nelson, L., Gibson, L.E., Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis (1994) J Pediatr, 124, pp. 255-260Portaria N° 288, 21 de Março de 2013. Diário oficial da união, Brasília, N° 56 - DOU - 22/03/13 - seção 1 , p. 47. , ftp://ftp.saude.sp.gov.br/ftpsessp/bibliote/informe_eletronico/2013/iels.mar.13/Iels55/U_PT-MS-SAS-288_210313.pdf, BrasilNumajiri, S., Sakurai, H., Sugibayashi, K., Morimoto, Y., Omiya, H., Takenaka, H., Akiyama, N., Comparison of depolarizing and direct current systems on iontophoretic enhancement of transport of sodium benzoate through human and hairless rat skin (1993) J Pharm Pharmcol, 45, pp. 610-613Zakzewski, C.A., Amory, D.W., Jasaitis, D.K., Li, J.K.J., Iontophoretically enhanced transdermal delivery of an ACE inhibitor in induced hypertensive rabbits: preliminary report (1992) CardiovascularDrugs and Therapy, 6, pp. 589-595Bagniefski, T.M., Burnette, R.R., A comparison of pulsed and continuous current iontophoresis (1990) J Cont Release, 11, pp. 113-122Preat, V., Thysman, S., Trandermaliontophoreric delivery of sulfentanilInt (1993) J Pharmaceut, 96, pp. 189-196(2000) Obesity: Preventing and managing the global epidemic, , Geneva: World Health Organization Technical Support Series, 894, Geneva: World Health OrganizationSousa, M., Servidoni, M.F., Vinagre, A.M., Ramalho, A.S., Bonadia, L.C., Felício, V., Ribeiro, M.A., Amaral, M.D., Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis (2012) Plos One, 7, p. e47708Carlsson, A.M., Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale (1983) Pain, 16, pp. 87-101Rosenstein, B.J., Cutting, G.R., The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel (1998) J Pediatr, 132, pp. 589-595Karezeski, B., Cutting, G., Diagnosis of cystic fibrosis. CFTR-related disease and screening (2006) ProgRespir Res, 34, pp. 69-76Strausbaugh, S.D., Davis, P.B., Cystic fibrosis: a review of epidemiology and pathobiology (2007) Clin Chest Med, 28, pp. 279-288Mackay, R., George, P., Kirk, J., Sweat testing for cystic fibrosis: A review of New Zealand laboratories (2006) J Paedia Child Health, 42, pp. 160-164Cirilli, N., Podan, R., Raia, V., Audit of sweat testing: A first report from Italian cystic fibrosis centres (2008) J Cystic Fibrosis, 7, pp. 415-422Kirk, J.M., Inconsistencies in sweat testing in UK laboratories (2000) Arch Dis Child, 82, pp. 425-427Webster, H.L., Laboratory diagnosis of cystic fibrosis (1983) CRC Crit Rev in Clin LabSci, 18, pp. 313-338http://www.wescor.com/biomedical/cysticfibrosis/macroduct.htmlSabbahi, M.A., Costello, C.T., Ernran, A., A method for reducing skin irritation by iontophoresis (1994) PhysTher, 74, p. S156Su, M.H., Srinivasan, V., Ghanem, A.H., Higuchi, W.I., Quantitative in vivo iontophoreticstudies (1994) J Pharm Sci, 83, pp. 12-17Huang, Y.-Y., Wu, S.-M., Transdermal Iontophoretic Delivery of Thyrotropin-Releasing Hormone Across Excised Rabbit Pinna Skin Drug Dev (1996) Ind Pharm, 22, pp. 1075-1081Knoblauch, P., Moll, F., In vitro pulsatile and continuous transdermal delivery of buserelin by iontophoresis (1993) J Control Release, 26, pp. 203-212Okabe, K., Yamaguchi, H., Kawai, Y., New iontophoretic transdermal administration of the beta-blocker metoprolol (1986) J Control Release, 4, pp. 79-85Li, S.K., Higuchi, W.I., Zhu, H., Kern, S.E., Miller, D.J., Hastings, M.S., In vitro and in vivo comparisons of constant resistance AC iontophoresis and DC iontophoresis (2003) J Control Release, 91, pp. 327-343Banga, A.K., Chien, Y.W., Iontophoretic delivery of drugs: fundamentals, developments and biomedical application (1988) J Control Rel, 7, p. 1Panzade, P., Heda, A., Puranik, P., Patni, M., Mogal, V., Enhanced Transdermal Delivery of Granisetron by Using Iontophoresis (2012) IJPR, 11, pp. 503-512Chen, L.L.H., Chien, Y.W., Transdermal iontophoretic permeation of luteinizing hormone releasing hormone: characterization of electric parameters (1996) J Control Release, 40, pp. 187-198Chien, Y.W., Siddiqui, O., Shi, W.M., Lelawongs, P., Liu, J.C., Direct current iontophoretic transdermal delivery of peptide and protein drugs (1989) J Pharm Sci, 78, pp. 376-383Hirvonen, J., Hueber, F., Guy, R.H., Current profile regulates iontophoretic delivery of amino acids across the skin (1995) J Control Release, 37, pp. 239-249Kanebako, M., Inagi, T., Takayama, K., Transdermal delivery of iondomethacin by iontophoresis (2002) Biol Pharm Bull, 25, pp. 779-782Abramowitz, D., Neoussikine, B., (1946) Treatment by Ion Transfer, p. 87. , NewYork: Grune and StrattonLeGrys, V.A., Applequist, R., Briscoe, D.R., Farrell, P., Hickstein, R., Lo, S.F., Passarell, R., Vaks, J.E., Sweat testing: sample collection and quantitative chloride analysisapproved guidelines - Third Edition (2009) Clin Lab Stand Ins, 29. , C34-A2Beauchamp, M., Lands, L.C., Sweat-Testing: A Review of Current Technical Requirements (2005) Pediatr Pulmonol, 39, pp. 507-511Chiang, C.H., Shao, C.H., Chen, J.L., Effects of pH electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide (1998) Drug Dev Ind Pharm, 24, pp. 431-438Van der Geest, R., Banhof, M., Bodde, H.E., Iontophoretic delivery of apomorphine I. In-vitro optimization and validation (1997) Pharm Res, 14, pp. 1798-1803Heap, S., Guidelines for the Performance of the Sweat Test for the Investigation of Cystic Fibrosis in the UK 2nd Version. An Evidence Based Guideline (2014) R College Paediatr Child Health, 2, pp. 1-121Kalia, Y.N., Naik, A., Garrison, J., Guy, R.H., Iontophoretic drug delivery (2004) Adv Drug DelivVer, 56, pp. 619-658Barry, B.W., Drug delivery routes in skin: a novel approach (2002) Adv Drug Deliv Rev, 54, pp. S31-S40Pikal, M.J., The role of electroosmotic flow in transdermal iontophoresis (1992) Adv Drug Deliv Rev, 9, pp. 201-237Curdy, C., Kalia, Y.N., Guy, R.H., Post-iontophoresis recovery of human skin impedance in vivo (2002) Eur J Pharm Biopharm, 53, pp. 15-21Ulreich, A., Leibrecht, W., Promer, M., Kullich, W., Infiltration versus iontophoresis in case of epicondylitis. A comparative study. Physikalische Medizin Rehabilitations medizin (1996) Kurortmedizin, 6, pp. 183-185Bolfe, V.J., Ribas, S.I., Montebelo, M.I.L., Guirro, R.R.J., Comportamento da impedância elétrica dos tecidos biológicos durante a estimulação elétrica transcutânea (2007) Rev Bras Fisioter, 11, pp. 153-159Bioelectrical impedance analysis-part I: review of principles and methods (2004) ClinNutr, 23, pp. 1226-1243Nakakura, M., Kato, Y., Hayakawa, E., Kuroda, T., Effect of pulse on iontophoretic delivery of desmopressin acetate in rats (1996) Biol Pharm Bull, 19, pp. 738-740Sagi-Dolev, A.M., Prutchi, D., Nathan, R.H., Three-dimensional current density distribuition under surface stimulation electrodes (1995) Med Biol Eng Comp, 33, pp. 403-408Zhu, F., Scheditz, D., Levin, N.W., Estimation of trunk extracellular volume by bioimpedance (1998) Conf Proc IEEE Eng Med Biol Soc, 20, pp. 3104-3107Chizmadzhev, Y.A., Kuzmin, P.I., Weaver, J.C., Potts, R.O., Skin appendageal macropores as a possible pat way for electrical current (1998) J Investg Dermatol Symp Proc, 3 (2), pp. 148-152Ya-Xian, R.O., Suetake, T., Tagami, H., Number of cell layers of the stratum corneum in normal skin-relationship to the anatomical location on the body, age, sex and physical parameters (1999) Arch Dermatol Res, 291, pp. 555-559Nelson, R.M., Hayes, K.W., Currier, D.P., (1999) Clinical Electrotherapy, pp. 15-54. , 3a. ed. Stanford: Appleton & LangeLow, J., Reed, A., (2000) Electrotherapy Explained: Principles and Practice, , Oxford: Butterworth-HeinemannCameron, M.H., (1999) Physical Agents in Rehabilitation: From Research to Practice, , Philadelphia: W.B.Saunders companyKubisz, L., The influence of storage time on the temperature dependence of the dc electrical conductivity of horn kereatin (2001) Bioelectrochemistry, 53, pp. 161-16

Neutron structure function and inclusive DIS from H-3 and He-3 at large Bjorken-x

A detailed study of inclusive deep inelastic scattering (DIS) from mirror A = 3 nuclei at large values of the Bjorken variable x is presented. The main purpose is to estimate the theoretical uncertainties on the extraction of the neutron DIS structure function from such nuclear measurements. On one hand, within models in which no modification of the bound nucleon structure functions is taken into account, we have investigated the possible uncertainties arising from: i) charge symmetry breaking terms in the nucleon-nucleon interaction, ii) finite Q**2 effects neglected in the Bjorken limit, iii) the role of different prescriptions for the nucleon Spectral Function normalization providing baryon number conservation, and iv) the differences between the virtual nucleon and light cone formalisms. Although these effects have been not yet considered in existing analyses, our conclusion is that all these effects cancel at the level of ~ 1% for x < 0.75 in overall agreement with previous findings. On the other hand we have considered several models in which the modification of the bound nucleon structure functions is accounted for to describe the EMC effect in DIS scattering from nuclei. It turns out that within these models the cancellation of nuclear effects is expected to occur only at a level of ~ 3%, leading to an accuracy of ~ 12 % in the extraction of the neutron to proton structure function ratio at x ~ 0.7 -0.8$. Another consequence of considering a broad range of models of the EMC effect is that the previously suggested iteration procedure does not improve the accuracy of the extraction of the neutron to proton structure function ratio.Comment: revised version to appear in Phys. Rev. C; main modifications in Section 4; no change in the conclusion

Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma

Glioblastoma is the most common and aggressive form of primary brain cancer, with no improvements in the 5-year survival rate of 4.6% over the past three decades. T-cellbased immunotherapies such as immune-checkpoint inhibitors and chimeric antigen receptor T-cell therapy have prolonged the survival of patients with other cancers and have undergone early-phase clinical evaluation in glioblastoma patients. However, a major challenge for T-cell-based immunotherapy of glioblastoma and other solid cancers is Tcell infiltration into tumours. This process is mediated by chemokine-chemokine receptor and integrin-adhesion molecule interactions, yet the specific nature of the molecules that may facilitate T-cell homing into glioblastoma are unknown. Here, we have characterised chemokine receptor and integrin expression profiles of endogenous glioblastomainfiltrating T cells, and the chemokine expression profile of glioblastoma-associated cells, by single-cell RNA-sequencing. Subsequently, chemokine receptors and integrins were validated at the protein level to reveal enrichment of receptors CCR2, CCR5, CXCR3, CXCR4, CXCR6, CD49a, and CD49d in glioblastoma-infiltrating T-cell populations relative to T cells in matched patient peripheral blood. Complementary chemokine ligand expression was then validated in glioblastoma biopsies and glioblastoma-derived primary cell cultures. Together, enriched expression of homing receptor-ligand pairs identified in this study implicate a potential role in mediating T-cell infiltration into glioblastoma. Importantly, our data characterising the migratory receptors on endogenous tumour-infiltrating T cells could be exploited to enhance the tumour-homing properties of future T-cell immunotherapies for glioblastoma.Paris M. Kollis, Lisa M. Ebert, John Toubia, Cameron R. Bastow, Rebecca J. Ormsby, Santosh I. Poonnoose, Sakthi Lenin, Melinda N. Tea, Stuart M. Pitson, Guillermo A. Gomez, Michael P. Brown, and Tessa Garget

Anomalous Pseudoscalar-Photon Vertex In and Out of Equilibrium

The anomalous pseudoscalar-photon vertex is studied in real time in and out of equilibrium in a constituent quark model. The goal is to understand the in-medium modifications of this vertex, exploring the possibility of enhanced isospin breaking by electromagnetic effects as well as the formation of neutral pion condensates in a rapid chiral phase transition in peripheral, ultrarelativistic heavy-ion collisions. In equilibrium the effective vertex is afflicted by infrared and collinear singularities that require hard thermal loop (HTL) and width corrections of the quark propagator. The resummed effective equilibrium vertex vanishes near the chiral transition in the chiral limit. In a strongly out of equilibrium chiral phase transition we find that the chiral condensate drastically modifies the quark propagators and the effective vertex. The ensuing dynamics for the neutral pion results in a potential enhancement of isospin breaking and the formation of $\pi^0$ condensates. While the anomaly equation and the axial Ward identity are not modified by the medium in or out of equilibrium, the effective real-time pseudoscalar-photon vertex is sensitive to low energy physics.Comment: Revised version to appear in Phys. Rev. D. 42 pages, 4 figures, uses Revte

First Results from the Arcminute Cosmology Bolometer Array Receiver

We review the first science results from the Arcminute Cosmology Bolometer Array Receiver (ACBAR); a multifrequency millimeter-wave receiver optimized for observations of the Cosmic Microwave Background (CMB) and the Sunyaev-Zel'dovich (SZ) effect in clusters of galaxies. ACBAR was installed on the 2 m Viper telescope at the South Pole in January 2001 and the results presented here incorporate data through July 2002. We present the power spectrum of the CMB at 150 GHz over the range \ell = 150 - 3000 measured by ACBAR as well as estimates for the values of the cosmological parameters within the context of Lambda-CDM models. We find that the inclusion of Omega_Lambda greatly improves the fit to the power spectrum. We also observe a slight excess of small-scale anisotropy at 150 GHz; if interpreted as power from the SZ effect of unresolved clusters, the measured signal is consistent with CBI and BIMA within the context of the SZ power spectrum models tested.Comment: To be published in the proceedings of "The Cosmic Microwave Background and its Polarization", New Astronomy Reviews, (eds. S. Hanany and K.A. Olive). 10 pages, 2 figure

Measurement of the Bs0→J/ψKS0B_s^0\to J/\psi K_S^0 branching fraction

The $B_s^0\to J/\psi K_S^0$ branching fraction is measured in a data sample corresponding to 0.41$fb^{-1}$ of integrated luminosity collected with the LHCb detector at the LHC. This channel is sensitive to the penguin contributions affecting the sin2$\beta$ measurement from $B^0\to J/\psi K_S^0$ The time-integrated branching fraction is measured to be $BF(B_s^0\to J/\psi K_S^0)=(1.83\pm0.28)\times10^{-5}$. This is the most precise measurement to date

Measurement of the CP-violating phase \phi s in Bs->J/\psi\pi+\pi- decays

Measurement of the mixing-induced CP-violating phase phi_s in Bs decays is of prime importance in probing new physics. Here 7421 +/- 105 signal events from the dominantly CP-odd final state J/\psi pi+ pi- are selected in 1/fb of pp collision data collected at sqrt{s} = 7 TeV with the LHCb detector. A time-dependent fit to the data yields a value of phi_s=-0.019^{+0.173+0.004}_{-0.174-0.003} rad, consistent with the Standard Model expectation. No evidence of direct CP violation is found.Comment: 15 pages, 10 figures; minor revisions on May 23, 201

Model-independent search for CP violation in D0→K−K+π−π+ and D0→π−π+π+π− decays

A search for CP violation in the phase-space structures of D0 and View the MathML source decays to the final states K−K+π−π+ and π−π+π+π− is presented. The search is carried out with a data set corresponding to an integrated luminosity of 1.0 fb−1 collected in 2011 by the LHCb experiment in pp collisions at a centre-of-mass energy of 7 TeV. For the K−K+π−π+ final state, the four-body phase space is divided into 32 bins, each bin with approximately 1800 decays. The p-value under the hypothesis of no CP violation is 9.1%, and in no bin is a CP asymmetry greater than 6.5% observed. The phase space of the π−π+π+π− final state is partitioned into 128 bins, each bin with approximately 2500 decays. The p-value under the hypothesis of no CP violation is 41%, and in no bin is a CP asymmetry greater than 5.5% observed. All results are consistent with the hypothesis of no CP violation at the current sensitivity